Effect of Hepatic Impairment on the Pharmacokinetics of a Single Dose of TD-9855
Clinical trial NCT04200573 · COMPLETED
Trial details
- NCT number
- NCT04200573
- Sponsor
- Theravance Biopharma
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-01-13
- Primary completion
- 2021-08-19
- Enrollment
- 31
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.